Curriculum Vitae

DR. JANET TAN SUI LING

Pharmacy Lecturer
  • Department of Pharmaceutical Technology
    Faculty of Pharmacy
  • janet.tan
  • 0379674909

ACADEMIC QUALIFICATION


  • PhD, (Philosophy)
    University of Nottingham
  • M.Pharm, (Pharmacy)
    Bath University, Bath, UK

MEMBERSHIPS


  • LIFETIME MEMBERSHIP OF MALAYSIAN PHARMACISTS SOCIETY (MPS), MEMBER
    Since 2023 (National)
  • ASSOCIATE MEMBER OF JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE (JSPS) ALUMNI ASSOCIATION MALAYSIA, MEMBER
    2023 to 2024 (National)
  • MEMBER OF THE MALAYSIA LOCAL CHAPTER OF THE CONTROLLED RELEASE SOCIETY, MEMBER
    2023 to 2024 (National)

AWARD AND STEWARDSHIP


  • Fellow of The Higher Education Academy (fhea)
    2025, Advance Higher Education,  (International)
  • Silver Medal Hari Inovasi Ppal 4.0
    2024, Universiti Malaysia Terengganu,  (National)
  • Silver Award in International University Carnival On E-learning (iucel) 2024
    2024, MINISTRY OF HIGHER EDUCATION,  (International)
  • Bronze Award in International University Carnival On E-learning (iucel) 2023
    2023, Universiti Malaysia Pahang,  (International)
  • Best Oral Presentation Award in 20th International Conference on Nanotechnology
    2018, World Academy of Science, Engineering and Technology, International
  • Best Oral Presenter in UNMC Link 17 Conference
    2017, UNIVERSITY OF NOTTINGHAM MALAYSIA, University
  • Royal Pharmaceutical Society Prize for Best Overall Third Year Student
    2015, UNIVERSITY OF BATH, UNITED KINGDOM, University
  • Pfizer Prize for Best Medicine Design in Third Year
    2015, UNIVERSITY OF BATH, UNITED KINGDOM, University
  • AstraZeneca Prize for Best in Cancer
    2015, UNIVERSITY OF BATH, UNITED KINGDOM, University
  • Vectura Prize for Best Advanced Drug Delivery
    2015, UNIVERSITY OF BATH, UNITED KINGDOM, University

PUBLICATIONS


Article in Journal
WoS
  1. Aththar, Ahmad Fariduddin; Raushani, Farhana; Sekaringtyas, Fransiska Christydira; El Muttaqien, Sjaikhurrizal; Setyawati, Damai Ria; Pratiwi, Riyona Desvy; Rifa'i, Muhaimin; Rahmawati, Siti Irma; Putra, Masteria Yunovilsa; Ahmadi, Peni; Indriani, Dwi Wahyu; Ling, Janet Tan Sui; Widyastuti, Endrika; Bayu, Asep; Rosyidah, A'liyatur (2025). Palm oil nanoemulsion enhances tocotrienol stability, antioxidant, and selective anti-melanoma activity, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. . doi:10.1007/s00210-025-04296-4
  2. Suhaili, Intan Nurul Annisha; Yow, Hui Yin; Mah, Siau Hui; Huri, Hasniza Zaman; Tan, Sui Ling Janet (2025). Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. . doi:10.1007/s00210-025-04446-8
  3. Rosyidah, A'liyatur; Pratiwi, Riyona Desvy; El Muttaqien, Sjaikhurrizal; Rahmawati, Siti Irma; Bayu, Asep; Tan, Sui Ling Janet; Gustini, Nunik; Ahmadi, Peni; Putra, Masteria Yunovilsa (2024). A facile and simple synthesis of a cytotoxic tocotrienol-based nanoemulsion against MCF-7 and A549 cancer cell lines, COLLOID AND POLYMER SCIENCE. . doi:10.1007/s00396-024-05245-y
  4. Yow, Hui-Yin; Ikawati, Muthi; Siswanto, Soni; Hermawan, Adam; Rahmat, Alim Khodimul; Tan, Janet Sui-Ling; Tee, Ying-Chew; Ng, Kok-Peng; Ikawati, Zullies (2024). Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review, PHARMACOGENOMICS. . doi:10.1080/14622416.2024.2344430
  5. Pang, Li Wen; Hamzah, Sharina; Tan, Sui Ling Janet; Mah, Siau Hui; Yow, Hui Yin (2023). The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review, NEUROCHEMICAL RESEARCH. . doi:10.1007/s11064-023-04005-8
Others
  1. Tan SLJ and Billa N. (2021). Improved bioavailability of poorly soluble drugs through gastrointestinal muco-adhesion of lipid nanoparticles. Pharmaceutics.13:1817-1846.
  2. Tan SLJ, Roberts CJ, Billa N. (2019) Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-loaded nanostructured lipid carrier (NLC) in rats. J Biomater Sci Polym Ed. 31:141-154.
  3. Tan SLJ, Billa N, Roberts CJ. (2018). Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B. PharmDevTechnol. 24:504-512.
  4. Tan SLJ, Roberts CJ, Billa N. (2019). Antifungal and mucoadhesive properties of an orally administered chitosan-coated amphotericin B nanostructured lipid carrier (NLC). AAPS PharmSciTech. 20:1-11.
Chapter in Books
  1. Bakry, M. M. , Huri, Z. H.,Vijayaprakash, S., Toh, G. T., Chua, E. W., Tan, S.L.J. and Yow, H.Y. (2025) Interplay Between Genetic Variants and Morphine: Toward Personalized Medicine in Cancer Pain Management. Cancer Immunology and Genetics: An Interdisciplinary Approach (pp 815-837). Springer.
Article in Proceeding
  1. Tan, S. L. J., Nik Adnan, N.N. (2023). Questionnaire Validation on Knowledge and Perception of Prescribers on Generics and Biosimilars in Oncology. Malaysian Journal of Pharmacy. 9(2), 50-59. doi: 10.52494/WSRB3977

RESEARCH PROJECT


National
  1. 2024 - 2027, UNIVERSITI MALAYA RESEARCH EXCELLENCE GRANT (UMREG)
    Exploring Chitosan-Coated Lipid Nanoparticles-Microalgae Microbot for Rifampicin and Isoniazid Pulmonary Delivery in Tuberculosis: Optimising Drug Loading and Lungs Retention In Vivo ( Principal Investigator(PI))
  2. 2024 - 2026, Fundamental Research Grant Scheme (FRGS)
    Investigating In-vitro Neuroprotective Effects And In-vivo Pharmacokinetics Properties Of Intranasally Administered 3-(4-phenylbutoxy) Xanthone Lipid Nanocarriers. ( Principal Investigator(PI))
  3. 2023 - 2025, UM International Collaboration Grant
    A Novel Approach to Tackle Mycobacterium Tuberculosis with Co-Encapsulated Rifampin and Isoniazid in Chitosan-Coated Nanoparticles. ( Principal Investigator(PI))
  4. 2023 - 2025, UM International Collaboration Grant
    Investigating The Role Of Genetic Polymorphisms Of Ugt1a9 On Pharmacokinetics Of Mycophenolic Acid In Renal Transplant Patients_ ( Co-Researcher)
International
  1. 2023 - 2024, International Funding
    Development of Curcumin and Rutin in Amorphous Solid Dispersions and Their Downstream Processing into Sublingual Tablets for Antituberculosis, National Cheng Kung University ( Co-Researcher)
University
  1. 2024 - 2026, Bantuan Khas Penyelidikan (BKP Special)
    Development Of Temperature Responsive Beads For Topical Delivery Of Turmeric: An Approadh To Enhanced Skin Therapeutics ( Co-Researcher)
  2. 2023 - 2025, University Grant
    Rifiso: A Novel Approach To Tackle Mycobacterium Tuberculosis With Co-encapsulated Rifampin And Isoniazid In Chitosan-coated Nanoparticles ( Principal Investigator(PI))
  3. 2023 - 2024, University Grant - Managed by ADEC
    Breaking The Code: The Ethics And Legislation Escape Room In Pharmacy Education ( Principal Investigator(PI))

CONSULTANCY PROJECT


  • Consultant Pharmacist for Rhazes Telepharmacy, RHAZES CONSULTANCY SERVICES SDN BHD, Consultant
    09 Oct 2023 - 08 Oct 2024 (National)

SUPERVISION


Under Graduate Students
  1. (2023) Perception of Third Year Pharmacy Students in OIA 3015 Ethics and Legislation Escape Room
  2. (2023) GKI 1001 PENYELIDIKAN BEBAS (INDEPENDENT RESEARCH)
  3. (2023) Development of chitosan-coated lipid nanoparticles for pulmonary delivery focussed on tuberculosis treatment
  4. (2023) Development of Chitosan-coated Lipid Nanoparticles Encapsulating Rifampin and Isoniazid for Pulmonary Delivery Focused on Tuberculosis Treatment
  5. (2023) Assessing the Knowledge of Third Year Pharmacy Students via OIA 3015 Ethics and Legislation Escape Room
Postgraduate Student
PhD/ Doctoral
  1. (2024) The Therapeutic Potential of Zerumbone-Loaded Nanoparticles in Mitigating Cellular Ageing, Wen Hwei Lee (Monash University Malaysia Campus)
  2. (2024) BETA LAPACHONE NANOCRYSTAL EMBEDDED IN FAST DISSOLVING NANOFIBER FOR ORAL MUCOSAL ADMINISTRATION, RULA RAJI METRI HADDADIN
  3. (2024) EXPLORING CHITOSAN-COATED LIPID NANOPARTICLES-MICROALGAE MICROBOT FOR RIFAMPICIN AND ISONIAZID PULMONARY DELIVERY IN TUBERCULOSIS: OPTIMISING DRUG LOADING AND LUNGS RETENTION IN VIVO, NUR AFIFAH BINTI OTHMAN
Master
  1. (2024) Development of chitosan-modified polylactide nanoparticles for local delivery of metronidazole in periodontics and its evaluations according to the Malaysian Drug Registration Guideline, GAN HIM KAI
  2. (2024) Development of simvastatin and Metronidazole-Loaded Chitosan-Modified Polylactic Acid Nanoparticles for Local Drug Delivery in Periodontal Disease, YU YANG
  3. (2024) A NOVEL APPROACH TO TACKLE MYCOBACTERIUM TUBERCULOSIS WITH CO-ENCAPSULATED RIFAMPIN AND ISONIAZID IN CHITOSAN-COATED NANOPARTICLES, FARAH NATASYA BINTI ZAMANI
  4. (2024) INVESTIGATING IN-VITRO NEUROPROTECTIVE EFFECTS OF INTRANASALLY ADMINISTERED 3-(4-PHENYLBUTOXY) XANTHONE LIPID NANOCARRIERS, INTAN NURUL ANNISHA BINTI SUHAILI
  5. (2023) Revolutionizing denture care : The Innovative Eugenol – Based Tablet Denture Cleanser - An Invitro Pilot Study, Jegadeesbari Ganapathy (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))